Home
Storia in 3 fonti
AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.
- ·
cnbc.com
AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
AstraZeneca CEO Pascal Soriot said the U.K.-listed company had many reasons to be in the U.S., adding that it was "rapidly transferring manufacturing" across the Atlantic.
- ·
telegraph.co.uk
UK-listed AstraZeneca: ‘We are a very American company’
Pascal Soriot declares his ‘love’ for US amid fears his pharma giant could quit the FTSE
- ·
theguardian.com
AstraZeneca chief executive hails ‘vital importance of US’ as Trump tariffs loom
Pascal Soriot refuses to be drawn, however, on reports AZ could move its main stock market listing across the Atlantic